ARTEMISMED
Artemis Medicare Services Limited (ARTEMISMED) Stock Analysis
Artemis Medicare Services Limited operates the Artemis chain of multi-specialty hospitals in North India. It provides tertiary care in cardiology, oncology, orthopedics, and other specialties. The company is backed by private equity and focuses on premium healthcare delivery. It is a listed hospital stock.
₹357.70
+5.67% 1W | +43.40% 52W
Market Cap
–
P/E Ratio
156.2
52W High
₹378.8
52W Low
₹203.3
Div. Yield
0%
Beta
0.3
50 DMA
₹314.7
200 DMA
₹267.6
Profit Margin
10.2%
Inst. Own.
1.4%
🔥 APPROACHING RESISTANCE
🔥 APPROACHING RESISTANCE
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 210 | 225 | 219 | 225 | 223 | 241 | 232 | 240 | 255 | 275 | 272 | 279 | 287 |
| Expenses | 182 | 191 | 186 | 187 | 187 | 199 | 195 | 204 | 214 | 224 | 228 | 228 | 231 |
| Operating Profit | 28 | 34 | 33 | 38 | 36 | 42 | 37 | 36 | 41 | 51 | 45 | 52 | 56 |
| OPM % | 13% | 15% | 15% | 17% | 16% | 18% | 16% | 15% | 16% | 18% | 16% | 18% | 20% |
| Other Income | 1 | 2 | 2 | 2 | 4 | 7 | 9 | 12 | 7 | 8 | 4 | 8 | 5 |
| Interest | 7 | 8 | 8 | 9 | 8 | 8 | 8 | 8 | 7 | 7 | 7 | 6 | 6 |
| Depreciation | 9 | 10 | 10 | 11 | 11 | 11 | 11 | 12 | 11 | 12 | 12 | 13 | 13 |
| Profit before tax | 13 | 19 | 16 | 20 | 22 | 31 | 27 | 29 | 30 | 39 | 30 | 40 | 43 |
| Tax % | 26% | 28% | 29% | 29% | 24% | 28% | 23% | 20% | 29% | 24% | 25% | 25% | 26% |
| Net Profit | 10 | 14 | 12 | 14 | 17 | 22 | 21 | 23 | 21 | 30 | 22 | 30 | 31 |
| EPS in Rs | 0.72 | 1.00 | 0.85 | 1.04 | 1.22 | 1.62 | 1.50 | 1.67 | 1.53 | 2.16 | 1.41 | 1.90 | 1.98 |
| Metric | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 547 | 565 | 408 | 555 | 737 | 879 | 937 | 1,081 | 1,114 |
| Expenses | 481 | 503 | 373 | 487 | 643 | 746 | 785 | 893 | 910 |
| Operating Profit | 66 | 62 | 35 | 68 | 94 | 133 | 152 | 188 | 203 |
| OPM % | 12% | 11% | 9% | 12% | 13% | 15% | 16% | 17% | 18% |
| Other Income | 2 | 4 | 7 | 3 | 7 | 7 | 33 | 27 | 25 |
| Interest | 11 | 13 | 13 | 12 | 20 | 31 | 32 | 28 | 27 |
| Depreciation | 20 | 23 | 22 | 22 | 31 | 40 | 45 | 48 | 50 |
| Profit before tax | 37 | 31 | 8 | 37 | 51 | 68 | 108 | 139 | 152 |
| Tax % | 45% | 36% | 18% | 16% | 25% | 28% | 24% | 25% | |
| Net Profit | 20 | 19 | 6 | 31 | 38 | 49 | 82 | 104 | 114 |
| EPS in Rs | 0.97 | 1.49 | 0.49 | 2.40 | 2.88 | 3.62 | 6.00 | 6.55 | 7.45 |
| Dividend Payout % | -0% | -0% | -0% | -0% | 16% | 12% | 7% | 7% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 14.0% | 22.0% | – |
| Profit CAGR | 41.0% | 77.0% | – |
Shareholding Pattern
Promoters66.53%
FIIs0.24%
DIIs4.76%
Public21.45%
Promoters66.53%
FIIs0.37%
DIIs4.27%
Public21.81%
Promoters58.38%
FIIs12.47%
DIIs2.91%
Public20.07%
Promoters58.39%
FIIs12.19%
DIIs2.89%
Public20.37%
Promoters58.39%
FIIs12.28%
DIIs2.40%
Public20.76%
Promoters68.91%
DIIs1.37%
Public22.43%
Promoters68.03%
FIIs0.10%
DIIs2.61%
Public22.08%
Promoters67.17%
FIIs0.31%
DIIs5.04%
Public20.39%
Promoters58.39%
FIIs12.19%
DIIs2.89%
Public20.37%
Promoters58.39%
FIIs12.28%
DIIs2.40%
Public20.76%
ARTEMISMED
Holdings Analysis
Key strengths & risk signals
65
Overall
42
Fundamental
88
Technical
Risks (1)
Cannot calculate PEG - insufficient growth data.
Strengths (3)
BULLISH TREND! 50-day average (314.7) is above 200-day average (267.6) - positive signal.
GOOD YEAR! Stock gained 43.4% in the last year.
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 1,705,696 vs down days: 301,409. Ratio: 5.66x
Fundamental & Technical Analysis
65Overall
42Fundamental
88Technical
Fundamental Breakdown
Growth Quality
4/30
Revenue CAGR: 0% (DECLINING, 2/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
5/10
DECENT EFFICIENCY! 10.2% profit margin - acceptable profitability.
PEG Valuation
1/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
14/20
MODERATE PUBLIC HOLDING! 23.3% public ownership - balanced ownership structure.
Stability Index
5/10
Insufficient historical data for stability analysis.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (314.7) is above 200-day average (267.6) - positive signal.
Price Position
8/10
STRONG POSITION! Current price (357.7) is above both moving averages.
Trend Pattern
10/20
AT RESISTANCE! Stock is at key resistance level.
52W Performance
10/10
GOOD YEAR! Stock gained 43.4% in the last year.
Volume Sentiment
30/30
BULLISH SENTIMENT! In last 30 days: 15 up days, 15 down days. Avg volume on up days: 1,705,696 vs down days: 301,409. Ratio: 5.66x
RSI
3/5
BULLISH! RSI at 65.5 - positive momentum.
52W Range
5/5
STRONG! Trading at 88.0% of 52W range - near yearly highs.
Momentum
5/5
STRONG MOMENTUM! Price has grown across all timeframes - up 5.7% (1 week), 10.6% (1 month), 37.0% (3 months). Momentum is accelerating.
Beta
5/5
LOW VOLATILITY! Beta of 0.30 - stable stock, less market risk.
ARTEMISMED
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-10 | Concall PDF | |
| Q4FY262026-05-15 | Concall PDF | |
| Q3FY262026-02-09 | Concall PDF | |
| Q2FY262025-11-18 | Concall PDF |
Peer Comparison
· · 1 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ARTEMISMED | ₹357.70 | 156.2 | 10.2% | – | – | +43.4% | 65 | APPROACHING RESISTANCE | – | – | – | – |
Data from TradeAlone · Updated daily
